Effects of immunization against PCSK9 in an experimental model of breast cancer

INTRODUCTION: Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an efficient strategy for lowering low-density lipoprotein cholesterol (LDL-C). There are, however, scant data on the efficacy and safety of PCSK9 inhibitors in non-cardiovascular diseases, particularly cancer. The prese...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Arch Med Sci
Autores principales: Momtazi-Borojeni, Amir Abbas, Nik, Maryam Ebrahimi, Jaafari, Mahmoud Reza, Banach, Maciej, Sahebkar, Amirhossein
Formato: Artigo
Lenguaje:Inglês
Publicado: Termedia Publishing House 2019
Materias:
Hot Topics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524183/
https://ncbi.nlm.nih.gov/pubmed/31110521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2019.84734
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares